CLB
Core Laboratories Inc. /DE/Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Free cash flow | $5.1M | Q4 2025 | — |
| Leverage ratio | 1.09 | Q4 2025 | — |
| Operating margin, ex-items (Production Enhancement) non-GAAP | 7% | Q4 2025 | — |
| Operating margin, ex-items (Reservoir Description) non-GAAP | 14% | Q4 2025 | — |
| Shares of common stock repurchased | 1.2M | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Oil & Gas Equipment & Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLB
this stock
Core Laboratories Inc. /DE/
|
$529.65M | -29.1% | +0.5% | 18.8 | 13.0% |
|
SLB
Slb Limited/Nv
|
$70.39B | +24.6% | -27.0% | 20.7 | 3.6% |
|
BKR
Baker Hughes Co
|
$56.05B | +26.2% | +20.6% | — | 2.5% |
|
HAL
Halliburton Co
|
$29.26B | +25.3% | +22.5% | — | 3.8% |
|
FTI
TechnipFMC plc
|
$28.71B | +62.4% | +16.8% | 27.6 | 3.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLB | +1.9% | -11.6% | -41.8% | -2.5% | -29.1% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +0.6% | -11.4% | -51.9% | -3.6% | -39.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.